Browse 24950 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
July 19th, 2017 |
Center for Coordination of Analytics, Science, Enhancement , and Logistics (CASEL) in Tobacco Regulatory Science (U54) |
National Institutes of Health |
March 24th, 2017 |
Tobacco Centers of Regulatory Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54) |
National Institutes of Health |
May 10th, 2017 |
FY2017 AmeriCorps Indian Tribes Grants |
Corporation for National and Community Service |
May 7th, 2020 |
Limited Competition: Analysis of Data from NIA's Alzheimer's Disease Sequencing Project Follow-Up Study (U01) |
National Institutes of Health |
November 4th, 2019 |
Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24) |
National Institutes of Health |
February 29th, 2020 |
NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01) |
National Institutes of Health |
November 4th, 2019 |
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3) |
National Institutes of Health |
November 4th, 2019 |
NCCIH Natural Product Phase II Clinical Trial Cooperative Agreement (U01) |
National Institutes of Health |
February 29th, 2020 |
Mind and Body Intervention Multi-Site Clinical Trial Data Coordinating Center (U24) |
National Institutes of Health |
February 29th, 2020 |
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3) |
National Institutes of Health |
May 7th, 2020 |
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44) |
National Institutes of Health |
May 7th, 2020 |
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3) |
National Institutes of Health |
May 7th, 2020 |
Nutrition and Alcohol-Related Health Outcomes (R21) |
National Institutes of Health |
May 7th, 2020 |
Nutrition and Alcohol-Related Health Outcomes (R03) |
National Institutes of Health |
May 7th, 2020 |
Nutrition and Alcohol-Related Health Outcomes (R01) |
National Institutes of Health |
September 25th, 2018 |
Research Education: Bridges to the Doctorate (R25) |
National Institutes of Health |
September 25th, 2018 |
Bridges to the Baccalaureate Program (R25) |
National Institutes of Health |
May 8th, 2017 |
Drug-Free Communities Mentoring Program |
Substance Abuse and Mental Health Services Adminis |
May 9th, 2017 |
Conducting Public Health Research in China |
Centers for Disease Control and Prevention ERA |
April 4th, 2017 |
Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30) |
National Institutes of Health |
|
July 25th, 2019 |
NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3) |
National Institutes of Health |
February 7th, 2019 |
Alliance of Glycobiologists for Cancer Research: Biological Tumor Glycomics Laboratories (U01) |
National Institutes of Health |
February 7th, 2019 |
Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories (U01) |
National Institutes of Health |
May 3rd, 2017 |
Addendum 05 - Health Supply Chains |
Agency for International Development |
May 17th, 2017 |
Alcohol-PTSD Comorbidity: Preclinical Studies of Models and Mechanisms (R01) |
National Institutes of Health |
May 9th, 2017 |
Detecting Cognitive Impairment, Including Dementia, in Primary Care and Other Everyday Clinical Settings for the General Public and in Health Disparities Populations (UG3/UH3) |
National Institutes of Health |
May 3rd, 2017 |
USAID's Essential Health Services Program (USAID's EHSP) |
Burma USAID Rangoon |
July 31st, 2019 |
NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1) |
National Institutes of Health |
January 15th, 2020 |
Inter-organelle Communication in Cancer (R01) |
National Institutes of Health |
January 15th, 2020 |
Inter-organelle Communication in Cancer (R21) |
National Institutes of Health |
May 7th, 2020 |
Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R21) |
National Institutes of Health |
March 5th, 2020 |
Hearing Health Care for Adults: Improving Access and Affordability (R01) |
National Institutes of Health |
May 7th, 2020 |
Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R03) |
National Institutes of Health |
May 7th, 2020 |
Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R01) |
National Institutes of Health |
May 26th, 2017 |
Addressing Emerging Infectious Diseases and the International Health Regulations |
Centers for Disease Control CGH |
April 7th, 2017 |
Global Health Security Partnership Engagement: Expanding Efforts and Strategies to Protect and Improve Public Health Globally |
Centers for Disease Control CGH |
April 7th, 2017 |
Protecting and Improving Public Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity, and Security |
Centers for Disease Control CGH |
April 7th, 2017 |
Affordable Care Act Program for Early Detection of Certain Medical Conditions Related to Environmental Health Hazards - Financed solely by 2017 Prevention and Public Health Funds |
Centers for Disease Control ATSDR |
May 5th, 2017 |
Continuation of Technical Collaboration to Strengthen and Expand Capacity to Assess, Prevent, and Mitigate the Effects of Public Health Threats of National and Global Importance with the Ministry of Public Health (MoPH) |
Centers for Disease Control CGH |
October 30th, 2018 |
Research Answers to NCI's Provocative Questions (R01) |
National Institutes of Health |